Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-22Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-04-24An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-14Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.Unknown journal · 2025-12-31The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.Unknown journal · 2025-12-25Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.Psychopharmacology · 2025-07-31Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Unknown journal · 2025-07-30Clinical pharmacology.Unknown journal · 2025-05-22A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant responseJournal of Psychopharmacology · 2024-09-19In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-28Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Unknown journal · 2024-01-31Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Unknown journal · 2024-01-10Safety pharmacology of acute psilocybin administration in healthy participantsNeuroscience Applied · 2023-12-31The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studiesJournal of Psychopharmacology · 2023-10-30Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participantsNeuropsychopharmacology · 2023-05-24Classic psychedelics do not affect T cell and monocyte immune responsesFrontiers in Psychiatry · 2023-01-19Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy ParticipantsClinical Pharmacology & Therapeutics · 2022-12-11Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology · 2022-02-24Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-01-24Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjectsNeuroscience Applied · 2021-12-31Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjectsNeuroscience Applied · 2021-12-31Dosing Psychedelics and MDMA.Unknown journal · 2021-12-31Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.Clinical Pharmacology & Therapeutics · 2021-11-21Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasmaJournal of Chromatography B · 2020-12-06MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogensNeuropsychopharmacology · 2020-11-19Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.Unknown journal · 2018-09-27Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Clinical pharmacokinetics · 2017-09-30Alterations of consciousness and mystical-type experiences after acute LSD in humans.Psychopharmacology · 2016-10-06Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.Unknown journal · 2016-05-19